MetaCap

Instil Bio Inc. Company Profile

NASDAQ: TILHealthcareBiotechnologyUSD

6.56-0.29 (-4.23%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Instil Bio at a glance

Instil Bio Inc. (NASDAQ: TIL) is a Biotechnology company in the Healthcare sector headquartered in Dallas, TX. Instil Bio is led by Mr. Bronson Crouch and employs about 17 people. The company's shares have traded publicly since 2021.

At a market capitalization of $44.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001789769, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Instil Bio do?

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Business description based on the company's public filings.

Company information

Legal name
Instil Bio Inc.
Ticker
NASDAQ: TIL
Industry
Biotechnology
CEO
Mr. Bronson Crouch
Employees
17
Headquarters
3963 Maple Avenue, Dallas, TX, United States
Phone
972 499 3350
IPO year
2021
Market cap
$44.49M
SEC CIK
0001789769
Latest annual report
10-K · Mar 27, 2026

Companies similar to Instil Bio

TIL peer companies
CompanyPrice% ChgMarket capCompare
HOWLWerewolf Therapeutics Inc.0.91-1.10%$44.23Mvs TIL
TVGNTevogen Inc.7.06+8.78%$45.97Mvs TIL
GRCEGrace Therapeutics Inc.2.04-2.86%$42.91Mvs TIL
CELUCelularity Inc. Class A1.46-0.68%$47.38Mvs TIL
ELTXElicio Therapeutics Inc.1.81-2.16%$47.57Mvs TIL
VERUVeru Inc.2.42-1.63%$41.26Mvs TIL
DWTXDogwood Therapeutics Inc.1.41-1.40%$47.93Mvs TIL
IMAImageneBio Inc.4.26-7.59%$48.45Mvs TIL

Related